Valuation : BioGaia AB

Market Cap 11.12B 1.16B 997M 939M 856M 1.6B 110B 1.61B 4.3B 56.32B 4.35B 4.26B 179B P/E 2026 *
28.7x
P/E 2027 * 23.4x
Enterprise Value 10.45B 1.09B 937M 883M 804M 1.5B 104B 1.51B 4.04B 52.94B 4.09B 4.01B 169B EV / Sales 2026 *
6.26x
EV / Sales 2027 * 5.58x
Free-Float
80.82%
Yield 2026 *
2.68%
Yield 2027 * 2.91%
1 day-0.45%
1 week-3.34%
Current month-4.18%
1 month-1.43%
3 months-10.14%
6 months-0.36%
Current year+3.48%
1 week 109.2
Extreme 109.2
114.9
1 month 109.2
Extreme 109.2
117.8
Current year 97.5
Extreme 97.5
136.3
1 year 96.2
Extreme 96.2
136.3
3 years 91.45
Extreme 91.45
139.7
5 years 68.88
Extreme 68.88
139.7
10 years 48.6
Extreme 48.6
139.7
Manager TitleAgeSince
Chief Executive Officer 60 30/09/2023
Director of Finance/CFO 59 05/11/2019
Chief Operating Officer 49 01/01/2021
Director TitleAgeSince
Chairman 77 01/01/2003
Chairman 76 25/04/2018
Director/Board Member 46 01/01/2015
Date Insider Type Main position Quantity % Market Cap. Importance
13/02/26 Buy

Director

582 0.0006%
30/12/25 Buy

General Counsel

390 0.0004%
05/12/25 Buy

Chief Financial Officer

2,000 0.0020%
Change 5-day change 1-year change 3-year change Capi.($)
-0.45%-3.34%+5.37%+14.18% 1.17B
-0.33%-1.96%+44.63%-2.77% 80.91B
-2.05%-0.64%-19.76%-36.79% 60.46B
-3.36%-12.10%+446.15%+25.98% 56.02B
+0.83%-4.47%-8.40%+30.44% 49.63B
-1.11%-6.36%-2.76%+147.94% 45.88B
-0.83%-2.46%+49.08%-18.63% 31.4B
+1.29%+0.80%+45.58%+96.95% 25.22B
-2.00%-3.35%-2.29%+177.79% 22.25B
-3.02%-3.10%+60.58%+104.24% 16.59B
Average -1.10%-1.45%+61.82%+53.93% 38.95B
Weighted average by Cap. -1.12%-1.14%+78.35%+38.17%

Financials

2026 *2027 *
Net sales 1.67B 174M 150M 141M 128M 240M 16.57B 241M 645M 8.46B 654M 640M 26.93B 1.88B 196M 168M 159M 144M 270M 18.63B 271M 725M 9.51B 735M 719M 30.27B
Net income 387M 40.38M 34.69M 32.69M 29.79M 55.71M 3.84B 55.92M 150M 1.96B 152M 148M 6.24B 474M 49.46M 42.49M 40.04M 36.48M 68.23M 4.71B 68.49M 183M 2.4B 186M 182M 7.65B
Net Debt -667M -69.6M -59.79M -56.35M -51.34M -96.02M -6.62B -96.38M -258M -3.38B -261M -256M -10.76B -646M -67.36M -57.86M -54.53M -49.68M -92.92M -6.41B -93.27M -250M -3.27B -253M -247M -10.41B
Logo BioGaia AB
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.
Employees
251
Date Price Change Volume
09/09/26 SEK 109.90 -0.45% 104,818
08/09/26 SEK 110.40 -0.72% 104,616
07/09/26 SEK 111.20 -1.94% 130,472
04/09/26 SEK 113.40 +1.70% 118,962
03/09/26 SEK 111.50 -1.68% 102,894
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
109.90SEK
Average target price
152.50SEK
Spread / Average Target
+38.76%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIOG B Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!